{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:21:35Z","timestamp":1791174095181,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40264-013-0106-y","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T12:31:54Z","timestamp":1382963514000},"page":"123-132","source":"Crossref","is-referenced-by-count":33,"title":["Evaluation of Disproportionality Safety Signaling Applied to Healthcare Databases"],"prefix":"10.1007","volume":"36","author":[{"given":"William","family":"DuMouchel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"Schuemie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Madigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"issue":"4","key":"106_CR1","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719\u201348.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"106_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.clpt.6100258","volume":"82","author":"JS Almenoff","year":"2007","unstructured":"Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N. Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther. 2007;82(2):157\u201366.","journal-title":"Clin Pharmacol Ther"},{"key":"106_CR3","doi-asserted-by":"crossref","unstructured":"DuMouchel W, Pregibon D. Empirical Bayes screening for multi-item associations. In: Proceedings of the seventh ACM SIGKDD international conference on Knowledge discovery and data mining. San Francisco: ACM; 2001. p. 67\u201376.","DOI":"10.1145\/502512.502526"},{"issue":"3","key":"106_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","volume":"53","author":"W Dumouchel","year":"1999","unstructured":"Dumouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999;53(3):177\u201390.","journal-title":"Am Stat"},{"issue":"1","key":"106_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0962280211403604","volume":"22","author":"GN Nor\u00e9n","year":"2013","unstructured":"Nor\u00e9n GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res 2013;22(1):57\u201369.","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"106_CR6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/14740338.4.5.929","volume":"4","author":"M Hauben","year":"2005","unstructured":"Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf. 2005;4(5):929\u201348.","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"106_CR7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2165\/00002018-200427100-00004","volume":"27","author":"M Hauben","year":"2004","unstructured":"Hauben M, Reich L. Safety related drug-labelling changes: findings from two data mining algorithms. Drug Saf. 2004;27(10):735\u201344.","journal-title":"Drug Saf"},{"issue":"6","key":"106_CR8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","volume":"25","author":"A Szarfman","year":"2002","unstructured":"Szarfman A, Machado SG, O\u2019Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA\u2019s spontaneous reports database. Drug Saf. 2002;25(6):381\u201392.","journal-title":"Drug Saf"},{"key":"106_CR9","doi-asserted-by":"crossref","unstructured":"Zorych I, Madigan D, Ryan P, Bate A. Disproportionality methods for pharmacovigilance in longitudinal observational databases. Stat Methods Med Res. 2013;22(1):39\u201356.","DOI":"10.1177\/0962280211403602"},{"issue":"6","key":"106_CR10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"106_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54(4):315\u201321.","journal-title":"Eur J Clin Pharmacol"},{"key":"106_CR12","doi-asserted-by":"crossref","unstructured":"Ryan PB, Schuemie M. Evaluating performance of risk identification methods through a large-scale simulation of observational data. Drug Saf. 2013 (in this supplement issue). doi: 10.1007\/s40264-013-0110-2 .","DOI":"10.1007\/s40264-013-0110-2"},{"key":"106_CR13","doi-asserted-by":"crossref","unstructured":"Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Desideratum for evidence based epidemiology. Drug Saf. 2013 (in this supplement issue). doi: 10.1007\/s40264-013-0102-2 .","DOI":"10.1007\/s40264-013-0102-2"},{"key":"106_CR14","doi-asserted-by":"crossref","unstructured":"Hartzema AG, Reich CG, Ryan PB, Stang PE, Madigan D, Welebob E, et al. Managing data quality for a drug safety surveillance system. Drug Saf. 2013 (in this supplement issue). doi: 10.1007\/s40264-013-0098-7 .","DOI":"10.1007\/s40264-013-0098-7"},{"issue":"4","key":"106_CR15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0272989X0002000410","volume":"20","author":"SB Cantor","year":"2000","unstructured":"Cantor SB, Kattan MW. Determining the area under the ROC curve for a binary diagnostic test. Med Decis Making. 2000;20(4):468\u201370.","journal-title":"Med Decis Making."},{"key":"106_CR16","doi-asserted-by":"crossref","unstructured":"Fram DM, Almenoff JS, DuMouchel W. Empirical Bayesian data mining for discovering patterns in post-marketing drug safety. In: Proceedings of the Ninth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. Washington, DC: ACM; 2003. p. 359\u201368.","DOI":"10.1145\/956750.956792"},{"issue":"6","key":"106_CR17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pds.885","volume":"12","author":"JS Almenoff","year":"2003","unstructured":"Almenoff JS, DuMouchel W, Kindman LA, Yang X, Fram D. Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting. Pharmacoepidemiol Drug Saf. 2003;12(6):517\u201321.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"106_CR18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0149-2918(04)90181-6","volume":"26","author":"W DuMouchel","year":"2004","unstructured":"DuMouchel W, Smith ET, Beasley R, Nelson H, Yang X, Fram D, et al. Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. Clin Ther. 2004;26(7):1092\u2013104.","journal-title":"Clin Ther"},{"issue":"10","key":"106_CR19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2165\/00002018-200629100-00005","volume":"29","author":"JS Almenoff","year":"2006","unstructured":"Almenoff JS, LaCroix KK, Yuen NA, Fram D, DuMouchel W. Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department. Drug Saf. 2006;29(10):875\u201387.","journal-title":"Drug Saf"},{"issue":"8","key":"106_CR20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.rli.0000229742.54589.7b","volume":"41","author":"R Solomon","year":"2006","unstructured":"Solomon R, Dumouchel W. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects. Invest Radiol. 2006;41(8):651\u201360.","journal-title":"Invest Radiol"},{"issue":"1","key":"106_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10401230701844612","volume":"20","author":"W DuMouchel","year":"2008","unstructured":"DuMouchel W, Fram D, Yang X, Mahmoud RA, Grogg AL, Engelhart L, et al. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004). Ann Clin Psychiatry. 2008;20(1):21\u201331.","journal-title":"Ann Clin Psychiatry."},{"key":"106_CR22","doi-asserted-by":"crossref","unstructured":"Harpaz R, DuMouchel W, LePendu P, Bauer-Mehren A, Ryan P, Shah NH. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther. 2013;93(6):539\u201346.","DOI":"10.1038\/clpt.2013.24"},{"issue":"10","key":"106_CR23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/MLR.0b013e31825f63bf","volume":"50","author":"MJ Schuemie","year":"2012","unstructured":"Schuemie MJ, Coloma PM, Straatman H, et al. Using electronic healthcare records for drug safety signal detection; a comparative evaluation of statistical methods. Med Care. 2012;50(10):890\u20137.","journal-title":"Med Care"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0106-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-013-0106-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0106-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T23:30:42Z","timestamp":1716075042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-013-0106-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":23,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1007\/s40264-013-0106-y","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}